Matches in Wikidata for { <http://www.wikidata.org/entity/Q65352388> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q65352388 description "clinical trial" @default.
- Q65352388 description "ensayu clínicu" @default.
- Q65352388 description "klinisch onderzoek" @default.
- Q65352388 description "клінічне випробування" @default.
- Q65352388 name "A Pharmacokinetic (PK) and Pharmacodynamic (PD) Dose-ranging Phase II Study of Ticagrelor in Paediatric Patients With Sickle Cell Disease" @default.
- Q65352388 name "A Pharmacokinetic" @default.
- Q65352388 type Item @default.
- Q65352388 label "A Pharmacokinetic (PK) and Pharmacodynamic (PD) Dose-ranging Phase II Study of Ticagrelor in Paediatric Patients With Sickle Cell Disease" @default.
- Q65352388 label "A Pharmacokinetic" @default.
- Q65352388 prefLabel "A Pharmacokinetic (PK) and Pharmacodynamic (PD) Dose-ranging Phase II Study of Ticagrelor in Paediatric Patients With Sickle Cell Disease" @default.
- Q65352388 prefLabel "A Pharmacokinetic" @default.
- Q65352388 P1132 Q65352388-1E572214-FD38-400F-B74A-8BBF20B73373 @default.
- Q65352388 P1476 Q65352388-5B5E93F1-71E9-4DD6-A74B-73741AA8220A @default.
- Q65352388 P17 Q65352388-3AF9AA24-CF19-4D15-9040-791D080BBDD5 @default.
- Q65352388 P17 Q65352388-3D64F759-2733-41F8-B3F5-7FD735D70C6D @default.
- Q65352388 P17 Q65352388-74F22CF3-3A79-49F7-A41E-1E953585022C @default.
- Q65352388 P17 Q65352388-B1785D11-2B6C-4122-8264-4AF65613B7A9 @default.
- Q65352388 P17 Q65352388-DDA9B0CC-D3CA-4D12-8A73-56D121F2E637 @default.
- Q65352388 P17 Q65352388-E1EBE573-3141-4872-B155-C105DC48A2F2 @default.
- Q65352388 P1813 Q65352388-D0ED096E-2126-421A-8326-4316BF6034A2 @default.
- Q65352388 P2899 Q65352388-66C4C21B-8C94-465D-BF54-545B79159C04 @default.
- Q65352388 P3098 Q65352388-EE3642EB-1EF1-4750-BF53-4C2F2CB1DA7E @default.
- Q65352388 P31 Q65352388-9349FFC5-F235-4D5D-BC5B-CECE2672A4A8 @default.
- Q65352388 P4135 Q65352388-7412B19F-C24C-4A18-94D8-F724F3AE42A3 @default.
- Q65352388 P580 Q65352388-9DF57715-CCAA-451B-B6D3-00665B866FEF @default.
- Q65352388 P582 Q65352388-5EB4EFA8-C2EE-4E38-93A7-1C5ABEBAD8CE @default.
- Q65352388 P6099 Q65352388-1E232876-4360-43FA-9BFE-E2553371BD30 @default.
- Q65352388 P8363 Q65352388-50D3D171-A2B6-4D7A-BCBE-F3E0C3B719D9 @default.
- Q65352388 P1132 "+46" @default.
- Q65352388 P1476 "Multicenter, Open-label, Randomised, Pharmacokinetic (PK) and Pharmacodynamic (PD) Dose-ranging Phase II Study of Ticagrelor Followed by a Double-blind, Randomised, Parallel-group, Placebo-controlled 4 Weeks Extension Phase in Paediatric Patients With Sickle Cell Disease" @default.
- Q65352388 P17 Q114 @default.
- Q65352388 P17 Q145 @default.
- Q65352388 P17 Q16 @default.
- Q65352388 P17 Q258 @default.
- Q65352388 P17 Q30 @default.
- Q65352388 P17 Q822 @default.
- Q65352388 P1813 "HESTIA 1" @default.
- Q65352388 P2899 "+2" @default.
- Q65352388 P3098 "NCT02214121" @default.
- Q65352388 P31 Q30612 @default.
- Q65352388 P4135 "+17" @default.
- Q65352388 P580 "2014-09-11T00:00:00Z" @default.
- Q65352388 P582 "2017-02-27T00:00:00Z" @default.
- Q65352388 P6099 Q42824440 @default.
- Q65352388 P8363 Q78089383 @default.